Intraductal papillary neoplasm of the left hepatic duct treated with endoscopic retrograde cholangiopancreatography guided radiofrequency ablation

Delaney, Steven; Zhou, Yi; Pawa, Swati; Pawa, Rishi

doi:10.1007/s12328-020-01284-4

Cited by 5 publications

(1 citation statement)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Radiofrequency energy, which induces coagulative necrosis of tumor tissue by a controlled temperature rise, has been widely employed as a method of tumor ablation. As reported by the previous studies ( 15 – 17 ), radiofrequency ablation has been adopted in a few IPNB cases and achieved promising results. In our case, considering that the successful results of radiofrequency ablation in malignant biliary obstruction, and previous patients with IPNB, as well as, a limited alternative to traditional surgical treatment, we put forward ERFA as a primary treatment modality for the patient with IPNB.…”

Section: Discussionmentioning

confidence: 73%

Endoscopic Endoluminal Radiofrequency Ablation and Single-Operator Peroral Cholangioscopy System (SpyGlass) in the Diagnosis and Treatment of Intraductal Papillary Neoplasm of the Bile Duct: A Case Report and Literature Review

et al. 2021

View full text Add to dashboard Cite

Background: Intraductal papillary neoplasm of the bile duct (IPNB) is a rare biliary benign tumor with atypical clinical features and is frequently misdiagnosed. Its treatment is limited and surgical resection is thought to be the only therapeutic option in patients with IPNB. With the aim of increasing the early diagnosis rate of IPNB and providing more therapeutic options for surgeons, we innovatively put forward the concept of combined utilization of SpyGlass and endoscopic endoluminal radiofrequency ablation (ERFA) in the diagnosis and treatment of IPNB.Case Presentation: An 85-year-old woman was referred to our hospital due to right upper quadrant abdominal pain. The image examinations indicated suspicious filling defects at the upper common bile duct. Further evaluation of SpyGlass cholangioscopy showed multiple reddish villous lesions at the left hepatic duct, and SpyBite biopsy under direct visualization demonstrated papillary low-grade dysplasia. In consideration of the advanced age and preference of the patient, the novel ERFA therapy was performed. The procedure was successful without periprocedural complications; the patient recovered uneventfully and was discharged 2 days after the operation. Upon follow-up, the patient was asymptomatic and in good physical condition at 8 months postoperatively.Conclusion: Preliminarily, we demonstrate that the strategy of a combination of SpyGlass and ERAF seems to be a promising, feasible, well-tolerated, and safe management for patients with IPNB. However, more data with larger patient volumes are needed to evaluate its outcomes further.

show abstract

Section: Discussionmentioning

confidence: 73%

Endoscopic Endoluminal Radiofrequency Ablation and Single-Operator Peroral Cholangioscopy System (SpyGlass) in the Diagnosis and Treatment of Intraductal Papillary Neoplasm of the Bile Duct: A Case Report and Literature Review

et al. 2021

View full text Add to dashboard Cite

show abstract

Intraductal papillary neoplasm of the bile duct: review of updated clinicopathological and imaging characteristics

Kim

Jang

2023

British Journal of Surgery

View full text Add to dashboard Cite

Background Intraductal papillary neoplasm of the bile duct (IPNB) is a relatively rare disease and is known as one of the premalignant lesions in the biliary tract. The concept of IPNB has changed through numerous studies and is still evolving. As a lesser studied clinical entity compared with its pancreatic counterpart, intraductal papillary mucinous neoplasm, IPNB has been described in many similar terms, including biliary papillomatosis, biliary intraductal papillary–mucinous neoplasm, and papillary cholangiocarcinoma. This is based on the diversity of histopathological spectrum of IPNB. Methods This review investigated previous studies including original articles, case studies, and expert opinions. Recently, two types of IPNB (types 1 and 2) have been proposed and validated based on the content first established in the WHO 2010 criteria. Results This review provides a comprehensive analysis of existing literature, summarizing the clinical, radiological, morphological, and pathological characteristics of IPNB. Conclusion Given the ongoing ambiguity and controversies surrounding IPNB, future research, including large population-based studies and molecular investigations, is essential to enhance understanding of this disease.

show abstract

Digital single‐operator cholangioscopy‐guided endoluminal radiofrequency of an intraductal papillary mucinous neoplasia of the bile duct

Deng,

Mou,

2024

Digestive Endoscopy

View full text Add to dashboard Cite

show abstract

Intraductal papillary neoplasm of the left hepatic duct treated with endoscopic retrograde cholangiopancreatography guided radiofrequency ablation

Cited by 5 publications

References 9 publications

Endoscopic Endoluminal Radiofrequency Ablation and Single-Operator Peroral Cholangioscopy System (SpyGlass) in the Diagnosis and Treatment of Intraductal Papillary Neoplasm of the Bile Duct: A Case Report and Literature Review

Endoscopic Endoluminal Radiofrequency Ablation and Single-Operator Peroral Cholangioscopy System (SpyGlass) in the Diagnosis and Treatment of Intraductal Papillary Neoplasm of the Bile Duct: A Case Report and Literature Review

Intraductal papillary neoplasm of the bile duct: review of updated clinicopathological and imaging characteristics

Digital single‐operator cholangioscopy‐guided endoluminal radiofrequency of an intraductal papillary mucinous neoplasia of the bile duct

Contact Info

Product

Resources

About